These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3520989)

  • 1. Inhibition of rat skin allograft rejection by cyclosporine. In situ characterization of the impaired local immune response.
    Guillén FJ; Hancock WW; Towpik E; Kupiec-Weglinski JW; Rickles FR; Tilney NL; Murphy GF
    Transplantation; 1986 Jun; 41(6):734-9. PubMed ID: 3520989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
    J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine and skin allografts for the treatment of thermal injury. I. Extensive graft survival with low-level long-term administration and prolongation in a rat burn model.
    Hewitt CW; Black KS; Aguinaldo AM; Achauer BM; Howard EB
    Transplantation; 1988 Jan; 45(1):8-12. PubMed ID: 3276067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor cell activity of cells infiltrating rat renal allografts prolonged by perioperative administration of extracted histocompatibility antigen and cyclosporine.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):708-13. PubMed ID: 2933856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that rat renal allografts are rejected by cytotoxic T cells and not by nonspecific effectors.
    Bradley JA; Mason DW; Morris PJ
    Transplantation; 1985 Feb; 39(2):169-75. PubMed ID: 3881855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness.
    Towpik E; Kupiec-Weglinski JW; Schneider TM; Tyler D; Padberg W; Araneda D; Tilney NL
    Transplantation; 1985 Dec; 40(6):714-8. PubMed ID: 3907046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine and anti-interleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms.
    Hancock WW; DiStefano R; Braun P; Schweizer RT; Tilney NL; Kupiec-Weglinski JW
    Transplantation; 1990 Feb; 49(2):416-21. PubMed ID: 2106180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival of skin allografts in rats treated with topical cyclosporine.
    Lai CS; Wesseler TA; Alexander JW; Babcock GF
    Transplantation; 1987 Jul; 44(1):83-7. PubMed ID: 3299925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection.
    Zhang H; Horwitz L; Ruvolo P; Colombani P; Hess AD
    Transplantation; 1995 Jul; 60(2):115-22. PubMed ID: 7624952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance of rat liver allografts induced by short-term selective immunosuppression combining monoclonal antibodies directed against CD25 and CD54 with subtherapeutic cyclosporine.
    Gassel HJ; Otto C; Gassel AM; Meyer D; Steger U; Timmermann W; Ulrichs K; Thiede A
    Transplantation; 2000 Mar; 69(6):1058-67. PubMed ID: 10762208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The survival and nature of the immune response to soft-tissue and composite-tissue allografts in rats treated with low-dose cyclosporine.
    Sobrado L; Pollak R; Robichaux WH; Martin PC; Sullivan KA; Swartz WM
    Transplantation; 1990 Sep; 50(3):381-5. PubMed ID: 2402786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that cyclosporine does not inhibit allograft rejection by IL-2-treated sensitized splenocytes.
    Kemeny MM; Stephens DA
    Transplantation; 1987 Apr; 43(4):560-3. PubMed ID: 3554645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyclosporine on distribution of macrophage subpopulations in rat hepatic allograft.
    Yamaguchi Y; Misumi M; Mori K; Takata N; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Takeya M
    Dig Dis Sci; 1993 Apr; 38(4):619-25. PubMed ID: 8462362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts.
    Makowka L; Chapman FA; Cramer DV; Qian SG; Sun H; Starzl TE
    Transplantation; 1990 Sep; 50(3):359-65. PubMed ID: 2402783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy.
    Kupiec-Weglinski JW; Sablinski T; Hancock WW; Di Stefano R; Mariani G; Mix CT; Tilney NL
    Transplantation; 1991 Feb; 51(2):300-5. PubMed ID: 1825240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production.
    Salom RN; Maguire JA; Hancock WW
    Transplantation; 1993 Dec; 56(6):1309-14. PubMed ID: 8278994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of acute rejection and cyclosporin A-treatment on induction of platelet-derived growth factor and its receptors during the development of chronic rat renal allograft rejection.
    Savikko J; Kallio EA; Taskinen E; von Willebrand E
    Transplantation; 2002 Feb; 73(4):506-11. PubMed ID: 11889420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Composite tissue allograft limb in rats immunosuppressed with cyclosporine A].
    Ishiguro N
    Nihon Seikeigeka Gakkai Zasshi; 1989 Dec; 63(12):1520-31. PubMed ID: 2625582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.